DENND4A and amyotrophic lateral sclerosis: Moreover, both CAMTA1 and DENND4A were independently found to be ‘Master Regulators’ (MRs) of neurodegenerative disease transcriptional programs in an in vivo Parkinson’s disease model and a cultured motor neuron-based ALS model (56,57).